The Economist @TheEconomist
Beta-amyloid is a protein which accumulates in plaques in the brains of those with Alzheimer’s. Lecanemab, an antibody, attaches itself to beta-amyloid and then attracts immune-system cells which clear the protein away https://t.co/5uuk4uqUb8 — PolitiTweet.org